» Articles » PMID: 23788657

Selective Agonists and Antagonists of Formylpeptide Receptors: Duplex Flow Cytometry and Mixture-based Positional Scanning Libraries

Overview
Journal Mol Pharmacol
Date 2013 Jun 22
PMID 23788657
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The formylpeptide receptor (FPR1) and formylpeptide-like 1 receptor (FPR2) are G protein-coupled receptors that are linked to acute inflammatory responses, malignant glioma stem cell metastasis, and chronic inflammation. Although several N-formyl peptides are known to bind to these receptors, more selective small-molecule, high-affinity ligands are needed for a better understanding of the physiologic roles played by these receptors. High-throughput assays using mixture-based combinatorial libraries represent a unique, highly efficient approach for rapid data acquisition and ligand identification. We report the superiority of this approach in the context of the simultaneous screening of a diverse set of mixture-based small-molecule libraries. We used a single cross-reactive peptide ligand for a duplex flow cytometric screen of FPR1 and FPR2 in color-coded cell lines. Screening 37 different mixture-based combinatorial libraries totaling more than five million small molecules (contained in 5,261 mixture samples) resulted in seven libraries that significantly inhibited activity at the receptors. Using positional scanning deconvolution, selective high-affinity (low nM K(i)) individual compounds were identified from two separate libraries, namely, pyrrolidine bis-diketopiperazine and polyphenyl urea. The most active individual compounds were characterized for their functional activities as agonists or antagonists with the most potent FPR1 agonist and FPR2 antagonist identified to date with an EC₅₀ of 131 nM (4 nM K(i)) and an IC₅₀ of 81 nM (1 nM K(i)), respectively, in intracellular Ca²⁺ response determinations. Comparative analyses of other previous screening approaches clearly illustrate the efficiency of identifying receptor selective, individual compounds from mixture-based combinatorial libraries.

Citing Articles

Development of small-molecule fluorescent probes targeting neutrophils -formyl peptide receptors.

Xu Q, Authi K, Kirpotina L, Schepetkin I, Quinn M, Cilibrizzi A RSC Med Chem. 2025; .

PMID: 39886349 PMC: 11775818. DOI: 10.1039/d4md00849a.


In Vivo Acute Toxicity Studies of Novel Anti-Melanoma Compounds Downregulators of hnRNPH1/H2.

Velayutham S, Seal T, Danthurthy S, Zaias J, Smalley K, Minond D Biomolecules. 2023; 13(2).

PMID: 36830718 PMC: 9953269. DOI: 10.3390/biom13020349.


Malaria Parasite Plasmodium falciparum Proteins on the Surface of Infected Erythrocytes as Targets for Novel Drug Discovery.

Oleinikov A Biochemistry (Mosc). 2022; 87(Suppl 1):S192-S177.

PMID: 35501996 PMC: 8802247. DOI: 10.1134/S0006297922140152.


A Novel Probe for Spliceosomal Proteins that Induces Autophagy and Death of Melanoma Cells Reveals New Targets for Melanoma Drug Discovery.

Palrasu M, Knapinska A, Diez J, Smith L, LaVoi T, Giulianotti M Cell Physiol Biochem. 2019; 53(4):656-686.

PMID: 31573152 PMC: 6990463. DOI: 10.33594/000000164.


Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors.

Krepel S, Wang J Int J Mol Sci. 2019; 20(14).

PMID: 31336833 PMC: 6678346. DOI: 10.3390/ijms20143426.


References
1.
Houghten R, Pinilla C, Giulianotti M, Appel J, Dooley C, Nefzi A . Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods. J Comb Chem. 2007; 10(1):3-19. DOI: 10.1021/cc7001205. View

2.
Khlebnikov A, Schepetkin I, Kirpotina L, Brive L, Dahlgren C, Jutila M . Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1. J Mol Model. 2011; 18(6):2831-43. PMC: 3314724. DOI: 10.1007/s00894-011-1307-x. View

3.
Dooley C, Houghten R . The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands. Life Sci. 1993; 52(18):1509-17. DOI: 10.1016/0024-3205(93)90113-h. View

4.
Burli R, Xu H, Zou X, Muller K, Golden J, Frohn M . Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents. Bioorg Med Chem Lett. 2006; 16(14):3713-8. DOI: 10.1016/j.bmcl.2006.04.068. View

5.
Frohn M, Xu H, Zou X, Chang C, McElvaine M, Plant M . New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation. Bioorg Med Chem Lett. 2007; 17(23):6633-7. DOI: 10.1016/j.bmcl.2007.09.043. View